Kailera, a portfolio company of RTW Biotech Opportunities (RTW), has announced positive topline data from the 8 mg dose of Hengrui Pharmaceutical’s Phase 2 clinical trial (HRS9531-203) of HRS9531, a GLP-1/GIP receptor dual agonist, in individuals living with obesity or overweight. The clinical trial results showed that a once-weekly subcutaneous injection of the 8 mg […]
The independent proxy advisors Glass Lewis and ISS have both published recommendations for shareholders of Henderson Opportunities Trust (HOT) in which they recommend HOT shareholders VOTE AGAINST all of the resolutions put forward by Saba Capital Management at the requisitioned general meeting that is being held on 4 February 2025 at 10am. HOT’s board’s message […]
Smithson (SSON) has published its letter to shareholders that is also its investment manger’s review for 2024. Simon Barnard, SSON’s investment manager, says that after a strong market sell-off in the last few days of the year, SSON’s final performance for 2024 can only be described as mediocre. He notes that it will also be […]
Patria Private Equity Trust (PPET) has agreed a three-year extension of its syndicated revolving multi-credit facility agreement (a loan facility) that takes effect from 3 February 2025 and also sees the amount available to borrow increasing from £300m £400m. Banco Santander, S.A. and State Street Bank & Trust Company are joining the syndicate of banks […]
In QuotedData’s morning briefing 27 January 2025: Odyssean Investment Trust (OIT) says that, following a review of its operational arrangements, NSM Funds (UK) Limited has been appointed as its company secretary with immediate effect. Reflecting this, the trust’s registered office will change to 46-48 James Street, London W1U 1EZ. CVC Income & Growth (CVCE) has […]
The independent proxy adviser ISS has published its recommendation in relation to the upcoming requisitioned general meeting for Keystone Positive Change (KPC) in which it recommends that KPC shareholders “VOTE AGAINST” all the resolutions proposed by Saba Capital. ISS states that Saba Capital has not presented a compelling case for change, let alone a case […]
All three of the major independent proxy advisers – Glass Lewis, ISS and PIRC – have published voting recommendations in relation to Baillie Gifford US Growth Trust’s (USA’s) upcoming requisitioned general meeting in which they all recommend that shareholders VOTE AGAINST ALL of resolutions proposed by Saba Capital. Furthermore, all three of these industry-leading governance […]
The independent proxy adviser, Glass Lewis, has published a voting recommendation in relation to The European Smaller Companies Trust’s upcoming requisitioned general meeting in which it recommends that shareholders VOTE AGAINST ALL of resolutions proposed by Saba Capital. So far, all of the recommendations that have been issued by all of the independent proxy advisers […]
Following an announcement on 8 November 2024 that its board was reviewing a range of options available for its future in advance of a continuation vote scheduled for September 2025, SVM UK Emerging (SVM) says that, after careful consideration, its board “does not believe that any of the options for the continuation of the Company […]
CQS Natural Resources Growth and Income (CYN) has issued a statement this morning reminding shareholders to vote in the upcoming general meeting (details of which are below, including all of the voting deadlines for the individual platforms) in which it urges shareholders to vote against the resolutions requisitioned by Saba Capital Management. The deadline to […]
